Calidi Biotherapeutics, Inc.CLDINYSE
Loading
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | -8.95% |
| Q2 2025 | 6.93% |
| Q1 2025 | 33.61% |
| Q4 2024 | -15.70% |
| Q3 2024 | -0.65% |
| Q2 2024 | -21.00% |
| Q1 2024 | -30.70% |
| Q4 2023 | 21.75% |
| Q3 2023 | 2.33% |
| Q2 2023 | 21.17% |
| Q1 2023 | 15.86% |
| Q4 2022 | 16.35% |
| Q3 2022 | 31.06% |
| Q2 2022 | -5.18% |
| Q1 2022 | 25.60% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |